Literature DB >> 3749801

Bile acid metabolism in patients with Crohn's disease in terminal ileum.

L Tougaard, B Giese, B H Pedersen, V Binder.   

Abstract

Bile acid metabolism was studied by means of the fractional turnover rate or orally ingested 14C-labeled taurocholic acid and by gas chromatographic determination of fecal excretion of the bile acids cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid (DCA), and lithocholic acid (LCA). Thirty patients with Crohn's disease (CD) of the small bowel, of whom 19 had been operated on with limited ileal resections, were studied and compared with 11 healthy volunteers. The unoperated group of CD patients did not show significant increase in bile acid excretion in the stools in contrast to the CD patients with ileal resection. The fecal excretion consisted mostly of primary bile acids, and a significant correlation between length of resection and bile acid excretion was found (rs = 0.81, p less than 0.01). The fractional turnover rate of CA + DCA was significantly increased in both unoperated (0.21 l/day) and operated (0.44 l/day) patients compared with normal controls (0.06 l/day). The bile acid pool of CA + DCA, however, was normal in patients with ileal resections, indicating a compensatory increase in bile acid synthesis. In unoperated patients the bile acid pool of CA + DCA was slightly decreased (3.1 mmol) compared with operated patients (6.2 mmol) and normal controls (4.8 mmol). The pool size was not significantly correlated to mean transit time of dietary residue, feces excretion, loss of weight, or amount of fat in feces. The mean transit time of dietary residue was decreased in both operated and unoperated CD patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749801     DOI: 10.3109/00365528609003110

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  9 in total

1.  Conditional Gata4 deletion in mice induces bile acid absorption in the proximal small intestine.

Authors:  Eva Beuling; Ilona M Kerkhof; Grace A Nicksa; Michael J Giuffrida; Jamie Haywood; Daniel J aan de Kerk; Christina M Piaseckyj; William T Pu; Terry L Buchmiller; Paul A Dawson; Stephen D Krasinski
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

2.  Primary bile acid diarrhoea without an ileal carrier defect: quantification of active bile acid transport across the ileal brush border membrane.

Authors:  A J van Tilburg; F W de Rooij; J W van den Berg; M van Blankenstein
Journal:  Gut       Date:  1991-05       Impact factor: 23.059

Review 3.  Role of the intestinal bile acid transporters in bile acid and drug disposition.

Authors:  Paul A Dawson
Journal:  Handb Exp Pharmacol       Date:  2011

Review 4.  Bile acid transporters.

Authors:  Paul A Dawson; Tian Lan; Anuradha Rao
Journal:  J Lipid Res       Date:  2009-06-04       Impact factor: 5.922

5.  Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease.

Authors:  Carsten Gnewuch; Gerhard Liebisch; Thomas Langmann; Benjamin Dieplinger; Thomas Mueller; Meinhard Haltmayer; Hans Dieplinger; Alexandra Zahn; Wolfgang Stremmel; Gerhard Rogler; Gerd Schmitz
Journal:  World J Gastroenterol       Date:  2009-07-07       Impact factor: 5.742

6.  Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease.

Authors:  Rian M Nijmeijer; Raffaella M Gadaleta; Saskia W C van Mil; Adriaan A van Bodegraven; J Bart A Crusius; Gerard Dijkstra; Daan W Hommes; Dirk J de Jong; Pieter C F Stokkers; Hein W Verspaget; Rinse K Weersma; C Janneke van der Woude; Janneke M Stapelbroek; Marguerite E I Schipper; Cisca Wijmenga; Karel J van Erpecum; Bas Oldenburg
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240

7.  Altered Bioavailability and Pharmacokinetics in Crohn's Disease: Capturing Systems Parameters for PBPK to Assist with Predicting the Fate of Orally Administered Drugs.

Authors:  Sarah Alrubia; Jialin Mao; Yuan Chen; Jill Barber; Amin Rostami-Hodjegan
Journal:  Clin Pharmacokinet       Date:  2022-09-03       Impact factor: 5.577

8.  Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis.

Authors:  Fiona D M van Schaik; Raffaella M Gadaleta; Frank G Schaap; Saskia W C van Mil; Peter D Siersema; Bas Oldenburg; Karel J van Erpecum
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

9.  Mechanism of Dyslipidemia in Obesity-Unique Regulation of Ileal Villus Cell Brush Border Membrane Sodium-Bile Acid Cotransport.

Authors:  Shanmuga Sundaram; Balasubramanian Palaniappan; Niraj Nepal; Shaun Chaffins; Uma Sundaram; Subha Arthur
Journal:  Cells       Date:  2019-10-03       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.